Best TouchPODCAST Podcasts (2024)

1
Selecting ART: Working with people living with HIV to find the best regimen 39:45

1h ago39:45

39:45

touchIN CONVERSATION for touchINFECTIOUS DISEASES Listen to a conversation between Dr Christoph Boesecke and Dr Tristan Barber, two experts on HIV practising in Germany and the UK. They respond to questions submitted by the HCP audience and provide their insights on best practices for antiretroviral therapy selection for people living with HIV. The…

1
Personalizing care within the MDT for patients with early through to advanced RCC 19:36

13h ago19:36

19:36

touchFOCUS for touchONCOLOGY Listen to Prof. Hans Hammers as he answers a series of questions on the application of prognostic markers and clinical data within the multidisciplinary team to personalize care for patients with early stage through to advanced and metastatic RCC. In addition, he responds to questions on the use of effective communicati…

1
Thyroid eye disease: An evolving continuum of care 38:00

5d ago38:00

38:00

touchPANEL DISCUSSION for touchOPHTHALMOLOGY Listen to a panel of leading experts discuss thyroid eye disease, including the underlying mechanisms, risk factors, symptomatology and burden of disease in affected patients, as well as the process for screening and diagnosing the disease. The experts Dr Andrea Kossler, Stanford University School of Med…

1
Intracranial haemorrhage related to direct oral anticoagulant medications: Latest evidence for reversal strategies 47:09

8d ago47:09

47:09

touchTALKS for touchNEUROLOGY A thrombosis and haemostasis expert shares insights into reversal strategies for patients with direct oral anticoagulant-associated intracranial haemorrhage (DOAC-ICH), including benefits and risks of DOAC use, evidence for DOAC reversal agents and guideline-directed management of the condition. The expert Prof. Dr. me…

1
Expanding the reach of HER2 in solid tumours: A spotlight on tumour-agnostic approaches 16:01

11d ago16:01

16:01

touchFOCUS for touchONCOLOGY Listen to Dr Dana Chase discuss the role of HER2 as a pan-tumour biomarker and the implications for treatment across various cancer types. The expert Dr Dana Chase - UCLA Health, Los Angeles, CA, USA This touchPODCAST is for HCPs only. This activity is funded by an independent medical education grant from AstraZeneca. T…

1
The path from detection to personalized long-term care for Fabry disease 36:05

13d ago36:05

36:05

touchEXPERT OPINIONS for touchENDOCRINOLOGY Listen to three leading Fabry disease experts discuss early diagnosis, organ monitoring, long-term individualized care and future directions. The experts Prof. Aleš Linhart, Charles University and General University Hospital, Prague, Czech Republic Dr Eric Wallace, University of Alabama at Birmingham Scho…

1
Demystifying virology: The link between the HIV life cycle and ART 37:54

13d ago37:54

37:54

touchEXPERT OPINIONS for touchINFECTIOUS DISEASES Listen to leading experts describe the HIV life cycle, the rationale for multidrug antiretroviral therapy (ART) regimens, mechanisms of ART resistance and how to manage it in people living with HIV. The experts Prof. Anne-Mieke Vandamme - Katholieke Universiteit Leuven, Belgium Prof. José Arribas - …

1
Knowledge for nurses ADC updates in breast cancer 40:21

14d ago40:21

40:21

touchIN CONVERSATION for touchONCOLOGY Listen to Ms Nikolina Dodlek, an oncology nurse from Croatia, in conversation with Professor Sherko Kümmel, a leading medical oncologist from Germany. They respond to questions submitted by the HCP audience and provide their expert insights on the use of HER2-directed antibody–drug conjugates (ADCs) in the tre…

1
Maximizing the possibilities in the evolving treatment paradigm for R/R follicular lymphoma 39:16

18d ago39:16

39:16

touchPANEL DISCUSSION for touchONCOLOGY Listen to a panel of leading experts discuss the latest evidence and clinical implications of recently approved treatments for relapsed/refractory follicular lymphoma (R/R FL), the importance of shared decision-making in treatment selection in the era of BsAb and CAR T-cell therapies, and the key consideratio…

1
Decoding HER2 in NSCLC: Advances in biomarker testing and targeted therapies 37:31

20d ago37:31

37:31

touchIN CONVERSATION for touchRESPIRATORY Listen to a medical oncologist and a pathologist as they discuss HER2 alterations in non-small cell lung cancer (NSCLC), including the different types of HER2 alterations, key considerations for HER2 testing and the latest data for HER2-targeting treatments. The experts Prof. Enriqueta Felip - Medical Oncol…

1
Early diagnosis and treatment of NMOSD: Practical insights 40:30

25d ago40:30

40:30

touchIN CONVERSATION for touchNEUROLOGY - Early diagnosis and treatment of NMOSD: Practical insights Listen to a neurologist and a neuro-ophthalmologist, both renowned experts in neuromyelitis optica spectrum disorder (NMOSD), answer questions from the ophthalmology and neurology communities on the management of NMOSD. They discuss presenting sympt…

1
Recognizing and managing HLH in the critical care setting: Best practice for the multidisciplinary team - Part 1 touchHAEMATOLOGY 14:00

27d ago14:00

14:00

touchMDT for touchHAEMATOLOGY Listen to an HLH specialist and a paediatric intensivist discuss the clinical features of HLH in patients and when it is important to have a high index of suspicion of HLH. The multidisciplinary team HLH specialist: Prof. Michael Jordan, Cincinnati, OH, USA Paediatric intensivist: Dr Kate Kernan, Pittsburgh, PA, USA Th…

1
Recognizing and managing HLH in the critical care setting: Best practice for the multidisciplinary team - Part 2 touchHAEMATOLOGY 11:34

27d ago11:34

11:34

touchMDT for touchHAEMATOLOGY Listen to an HLH specialist and a pathologist discuss the role of the pathologist in the diagnostic workup of patients suspected of having HLH, including the insights available from bone marrow biopsy in identifying triggers for HLH. The multidisciplinary team HLH specialist: Prof. Michael Jordan, Cincinnati, OH, USA P…

1
Recognizing and managing HLH in the critical care setting: Best practice for the multidisciplinary team - Part 3 touchHAEMATOLOGY 13:32

27d ago13:32

13:32

touchMDT for touchHAEMATOLOGY Listen to an HLH specialist, paediatric intensivist and critical care pharmacist discuss the importance of an individualized approach to the treatment of HLH, particularly when considering the age of the patient. The multidisciplinary team HLH specialist: Prof. Michael Jordan, Cincinnati, OH, USA Paediatric intensivist…

1
Recognizing and managing HLH in the critical care setting: Best practice for the multidisciplinary team - Part 4 touchHAEMATOLOGY 12:01

27d ago12:01

12:01

touchMDT for touchHAEMATOLOGY Listen to an HLH specialist and a paediatric intensivist discuss the standard of care for patients with primary HLH and highlight the introduction of novel agents for second-line therapy for patients who do not respond in the first line. The multidisciplinary team HLH specialist: Prof. Michael Jordan, Cincinnati, OH, U…

1
Recognizing and managing HLH in the critical care setting Best practice for the multidisciplinary team - Part 1 touchIMMUNOLOGY 14:00

27d ago14:00

14:00

touchMDT for touchIMMUNOLOGY Listen to an HLH specialist and a paediatric intensivist discuss the clinical features of HLH in patients and when it is important to have a high index of suspicion of HLH. The multidisciplinary team HLH specialist: Prof. Michael Jordan, Cincinnati, OH, USA Paediatric intensivist: Dr Kate Kernan, Pittsburgh, PA, USA Thi…

1
Recognizing and managing HLH in the critical care setting: Best practice for the multidisciplinary team - Part 2 touchIMMUNOLOGY 11:34

27d ago11:34

11:34

touchMDT for touchIMMUNOLOGY Listen to an HLH specialist and a pathologist discuss the role of the pathologist in the diagnostic workup of patients suspected of having HLH, including the insights available from bone marrow biopsy in identifying triggers for HLH. The multidisciplinary team HLH specialist: Prof. Michael Jordan, Cincinnati, OH, USA Pa…

1
Recognizing and managing HLH in the critical care setting: Best practice for the multidisciplinary team - Part 3 touchIMMUNOLOGY 13:32

27d ago13:32

13:32

touchMDT for touchIMMUNOLOGY Listen to an HLH specialist, paediatric intensivist and critical care pharmacist discuss the importance of an individualized approach to the treatment of HLH, particularly when considering the age of the patient. The multidisciplinary team HLH specialist: Prof. Michael Jordan, Cincinnati, OH, USA Paediatric intensivist:…

1
Recognizing and managing HLH in the critical care setting: Best practice for the multidisciplinary team - Part 4 touchIMMUNOLOGY 12:01

27d ago12:01

12:01

touchMDT for touchIMMUNOLOGY Listen to an HLH specialist and a paediatric intensivist discuss the standard of care for patients with primary HLH and highlight the introduction of novel agents for second-line therapy for patients who do not respond in the first line. The multidisciplinary team HLH specialist: Prof. Michael Jordan, Cincinnati, OH, US…

1
Let’s talk about agitation in Alzheimer’s dementia: Prevalence, behavioural symptoms and reaching a diagnosis 43:29

28d ago43:29

43:29

touchIN CONVERSATION for touchNEUROLOGY Listen to Dr Carolyn Clevenger, a gerontological nurse practitioner, in conversation with family care partner Ms Kathleen Rhyne. They respond to questions submitted by the HCP audience, providing valuable insights on agitation in Alzheimer’s dementia with a focus on prevalence, behavioural symptoms and the im…

1
Multidisciplinary insights: Navigating the challenges of systemic mastocytosis diagnosis and management 51:54

28d ago51:54

51:54

touchPANEL DISCUSSION for touchONCOLOGY Listen to a panel of leading experts—a renowned allergist, dermatologist, and haemato-oncologist—discuss the diagnosis and management of systemic mastocytosis, including current and emerging treatment options and multidisciplinary approaches to optimize patient care. The experts Prof. Dr Vito Sabato, Universi…

1
Multidisciplinary insights: Navigating the challenges of systemic mastocytosis diagnosis and management 51:55

28d ago51:55

51:55

touchPANEL DISCUSSION for touchIMMUNOLOGY Listen to a panel of leading experts a renowned allergist, dermatologist, and haemato-oncologist discuss the diagnosis and management of systemic mastocytosis, including current and emerging treatment options and multidisciplinary approaches to optimize patient care. The experts Prof. Dr Vito Sabato, Univer…

1
Immunotherapy for early-stage, resectable NSCLC 34:52

1M ago34:52

34:52

Prof. Heather Wakelee discusses the use of immune checkpoint inhibitors for early-stage, resectable NSCLC, considering the most recent data on pre-, post- and peri-operative immunotherapy and their impact on clinical practice. The expert Prof. Heather A Wakelee – Stanford University, CA, USA This touchPODCAST is for HCPs only. This activity is fund…

1
Impact of pharmacotherapies for achondroplasia – Discussion 4 / 4 19:20

2M ago19:20

19:20

touchMDT for touchENDOCRINOLOGY Listen to experts Prof. Karin Blakemore, Prof. Klaus Mohnike, Prof. Janet Legare and patient advocate Carly Kutner provide their insights on the impact of pharmacotherapies for achondroplasia The multidisciplinary team and patient advocate: MFM specialist - Prof. Karin Blakemore Johns Hopkins University School of Med…

1
Monitoring and early treatment initiation - Discussion 3 13:48

2M ago13:48

13:48

touchMDT for touchENDOCRINOLOGY Listen to experts Prof. Janet Legare and Prof. Klaus Mohnike, plus patient advocate Carly Kutner, explore the importance of monitoring and early treatment initiation in achondroplasia to reduce the risk of paediatric complications The multidisciplinary team and patient advocate: Paediatrician - Prof. Janet Legare Uni…

1
Early recognition of achondroplasia – Discussion 2 / 4 16:24

2M ago16:24

16:24

touchMDT for touchENDOCRINOLOGY Listen to experts Prof. Janet Legare, Prof. Karin Blakemore, Prof. Klaus Mohnike and patient advocate Carly Kutner explore the importance of early recognition of achondroplasia in reducing the risk of paediatric complications. The multidisciplinary team and patient advocate: Paediatrician - Prof. Janet Legare Univers…

1
MDT management of achondroplasia – Discussion 1 / 4 14:14

2M ago14:14

14:14

touchMDT for touchENDOCRINOLOGY Listen to key experts Prof. Klaus Mohnike, Prof. Karin Blakemore and Prof. Janet Legare discuss the multidisciplinary management of achondroplasia, including the importance of appropriate specialist referrals The multidisciplinary team: Paediatric endocrinologist - Prof. Dr. med. Klaus Mohnike Otto-von-Guericke Unive…

1
Advanced urothelial carcinoma: Expert guidance to navigate an evolving therapeutic landscape 32:08

2M ago32:08

32:08

touchEXPERT OPINIONS for touchONCOLOGY In this activity, Prof. Thomas Powles, an oncologist specializing in bladder cancer, provides an update on the latest developments in the treatment of advanced urothelial carcinoma, including the latest guideline recommendations, supporting clinical data and factors to support decision making in clinical pract…

1
Clinical decision making with immunotherapies in advanced or recurrent endometrial cancer 39:11

3M ago39:11

39:11

touchEXPERT OPINIONS for touchONCOLOGY A gynaecological oncologist considers the expanding role of molecular classification in endometrial cancer and provides an update on the use of immune checkpoint inhibitors to treat patients with advanced or recurrent disease, including key guideline recommendations, supporting data and considerations for clin…

1
Optimizing management of bronchiolitis obliterans syndrome: Current strategies, future directions 32:08

3M ago32:08

32:08

touchEXPERT OPINIONS for touchIMMUNOLOGY Three experts share their insights on how to optimize the care of patients with bronchiolitis obliterans syndrome, including the disease pathogenesis and the burden on patients, guideline-directed diagnostic strategies, and current and future treatment options. The experts Dr Michael Perch – University of Co…

1
Gastrointestinal oncology experts discuss precision medicine in the treatment of colorectal cancer 43:29

4M ago43:29

43:29

touchIN CONVERSATION for touchONCOLOGY Listen to Dr Juan Manuel O’Connor, a leading expert in colorectal cancer from Argentina, in conversation with Prof. Dr. Francesco Sclafani, a gastrointestinal oncology specialist from Belgium. They respond to questions submitted by the HCP audience and provide their expert insights on the use of precision medi…

1
Current treatments and unmet needs in limited-stage small cell lung cancer 15:53

4M ago15:53

15:53

touchFOCUS for touchRESPIRATORY Listen to a medical oncologist share her insights on the current treatments for LS-SCLC and the remaining unmet needs for patients. The expert Dr Anne Chiang – Yale School of Medicine, New Haven, CT, USA This touchPODCAST is for healthcare professionals outside of the UK only. This activity is funded by an independen…

1
How to recognize and diagnose agitation in Alzheimer’s dementia – Discussion 5 13:23

5M ago13:23

13:23

touchMDT for touchNEUROLOGY Listen to an advocate for individuals and families living with Alzheimer’s and other dementias interview a former Alzheimer’s dementia care partner; they explore the challenges of diagnosing agitation in Alzheimer’s dementia and the importance of a patient-centric multidisciplinary care team that encompasses care partner…

1
Understanding agitation in Alzheimer’s dementia – Discussion 4 11:00

5M ago11:00

11:00

touchMDT for touchNEUROLOGY Listen to an advocate for individuals and families living with Alzheimer’s and other dementias interview a former Alzheimer’s dementia care partner to share personal insights of how agitation impacts not only the person living with dementia but everyone around them. The multidisciplinary team Advocate: Ms Jennifer Pettis…

1
Managing agitation in Alzheimer’s dementia – Discussion 3 14:21

5M ago14:21

14:21

touchMDT for touchNEUROLOGY Listen to key experts from a multidisciplinary team discuss best practice management approaches for agitation in Alzheimer’s dementia. The multidisciplinary team Geriatric psychiatrist: Prof. George T Grossberg, St Louis, MO, USA Cognitive neurologist: Dr Alireza Atri, Sun City, AZ, USA Nurse practitioner: Ms Susan Scanl…

1
How to recognize and diagnose agitation in Alzheimer’s dementia – Discussion 2 13:19

5M ago13:19

13:19

touchMDT for touchNEUROLOGY Listen to key experts from a multidisciplinary team discuss the criteria for diagnosis of agitation in Alzheimer’s dementia; plus, a former care partner shares her insights on the challenges of diagnosis. The multidisciplinary team Geriatric psychiatrist: Prof. George T Grossberg, St Louis, MO, USA Cognitive neurologist:…

1
Understanding agitation in Alzheimer’s dementia – Discussion 1 12:52

5M ago12:52

12:52

touchMDT for touchNEUROLOGY Listen to key experts from a multidisciplinary team review the behavioural symptoms of agitation in Alzheimer’s dementia, and hear from a former care partner on how agitation impacts not only the person living with dementia but everyone around them. The multidisciplinary team Geriatric psychiatrist: Prof. George T Grossb…

1
Experts in diabetes discuss the latest developments in basal insulin therapy for type 2 diabetes management 43:38

5M ago43:38

43:38

touchIN CONVERSATION for touchENDOCRINOLOGY Listen to Dr Viswanathan Mohan in conversation with Dr Alice Y Y Cheng. They respond to questions submitted by the HCP audience and provide their expert insights regarding practical considerations for the use of basal insulin therapy in patients with type 2 diabetes, with a focus on the current and future…

Podcasts Worth a Listen

TouchPODCAST

Podcasts Worth a Listen

Quick Reference Guide